4th Quarter - Report

ALSTON & BIRD LLP for LANNETT COMPANY, INC.

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA drug approval policies; Drug fee and rebate rules under the Affordable Care Act; Issues related to FDA biosimilar Deemed to be a License guidance.

LobbyistCovered position, as disclosed
BRENDAN CARROLL —
JUSTIN M MANN New —
MARC SCHEINESON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.